Bill Miller - Miller Value Partners
Holding/activity history for  Alexion Pharmaceuticals Inc. (ALXN)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2020   Q1 | 0 | 0 | Sell 100.00% | 1.51 | |
2019   Q4 | 388,380 | 1.51 | Reduce 13.46% | 0.23 | $108.15 |
2019   Q3 | 448,780 | 1.78 | $97.94 | ||
2019   Q2 | 448,780 | 2.36 | Add 0.25% | 0.01 | $130.98 |
2019   Q1 | 447,680 | 2.41 | Reduce 0.10% | 0.00 | $135.18 |
2018   Q4 | 448,135 | 1.99 | Reduce 0.15% | 0.00 | $97.36 |
2018   Q3 | 448,825 | 2.08 | Add 1.46% | 0.03 | $139.01 |
2018   Q2 | 442,345 | 2.11 | Add 5.05% | 0.10 | $124.15 |
2018   Q1 | 421,065 | 2.06 | Reduce 3.62% | 0.08 | $111.46 |
2017   Q4 | 436,865 | 2.29 | Reduce 1.70% | 0.04 | $119.59 |
2017   Q3 | 444,425 | 2.91 | Reduce 1.40% | 0.04 | $140.29 |
2017   Q2 | 450,725 | 2.52 | Add 25.66% | 0.51 | $121.67 |
2017   Q1 | 358,700 | 2.26 | Add 259.74% | 1.63 | $121.24 |
2016   Q4 | 99,710 | 0.65 | Buy | 0.65 | $122.35 |